Outset Medical
(NASDAQ) OM
Outset Medical Financials at a Glance
Market Cap
$85.83M
Revenue (TTM)
$117.59M
Net Income (TTM)
-$74.85M
EPS (TTM)
-$4.18
P/E Ratio
-1.11
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Price
$4.62
Volume
6,363
Open
$4.80
Price
$4.62
Volume
6,363
Open
$4.80
Previous Close
$4.62
Daily Range
$4.62 - $4.99
52-Week Range
$3.00 - $21.36
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Price
$4.62
Volume
6,363
Open
$4.80
Previous Close
$4.62
Daily Range
$4.62 - $4.99
52-Week Range
$3.00 - $21.36
Estimated Earnings Date
Aug 5, 2026
OM News
OM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Outset Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
310
CEO
Leslie L. Trigg, MBA
Website
www.outsetmedical.comHeadquarters
San Jose, CA 95134, US
OM Financials
Key Financial Metrics (TTM)
Gross Margin
40.64%
Operating Margin
-56.93%
Net Income Margin
-63.65%
Return on Equity
-55.88%
Return on Capital
-29.24%
Return on Assets
-30.00%
Earnings Yield
-90.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$85.83M
Shares Outstanding
18.54M
Volume
6.36K
Avg. Volume
167.62K
Financials (TTM)
Gross Profit
$47.78M
Operating Income
-$67.23M
EBITDA
-$57.11M
Operating Cash Flow
-$33.51M
Capital Expenditure
-$740.00K
Free Cash Flow
-$34.25M
Cash & ST Invst.
$156.71M
Total Debt
$101.61M
Outset Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$27.86M
-6.3%
Gross Profit
$12.10M
+9.3%
Gross Margin
43.41%
N/A
Market Cap
$85.83M
N/A
Market Cap/Employee
$242.45K
N/A
Employees
354
N/A
Net Income
-$18.98M
+26.4%
EBITDA
-$14.60M
+3.4%
Quarterly Fundamentals
Total Cash
$156.71M
-17.1%
Total Debt
$101.61M
+3.5%
Accounts Receivable
$25.32M
-31.4%
Inventory
$49.65M
-11.0%
Long Term Debt
$99.79M
+3.6%
Short Term Debt
$1.82M
-1.7%
Return on Assets
-30.00%
N/A
Return on Invested Capital
-31.60%
N/A
Free Cash Flow
-$12.91M
+49.9%
Operating Cash Flow
-$12.84M
+50.0%